Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Glioblastoma

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Glioblastoma in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palumbo, P1
Lombardi, F1
Augello, FR1
Giusti, I1
Luzzi, S1
Dolo, V1
Cifone, MG1
Cinque, B1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Glioblastoma

ArticleYear
NOS2 inhibitor 1400W Induces Autophagic Flux and Influences Extracellular Vesicle Profile in Human Glioblastoma U87MG Cell Line.
    International journal of molecular sciences, 2019, Jun-20, Volume: 20, Issue:12

    Topics: Amidines; Autophagy; Benzylamines; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Inh

2019